Composition including naphthoquinone compound for treating and preventing hearing loss
A technology for hearing loss and composition, which is applied in the direction of drug combination, active ingredients of heterocyclic compounds, medical preparations containing active ingredients, etc., and can solve the problems of unapproved prevention and treatment of hearing loss
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment Embodiment 1
[0088] Experimental Example 1: Animal Model of Age-Related Presbycusis
example 1-1
[0089] Laboratory Example 1-1: Preparation of Animal Models
[0090] C57BL / 6 mice known as a model of age-related hearing loss were used for this experiment. 12-month-old C57BL / 6 mice were purchased directly from the Animal Company Experiment Center (Central Lab. Animal Inc., Seoul, Korea), and raised to 24 months of age, while hearing loss was measured every 3 months. All mice used in this experiment were housed in a sterile (germfree) animal facility maintained at constant temperature (22–26°C) and humidity (55–60%).
[0091] All experiments were performed on all groups divided into a control group fed ad libitum with normal feed, a caloric restriction (CR) group restricted to 70% of the diet, and a βL group fed a feed containing 0.06% β-lapachone (Compound I). Group.
experiment Embodiment 1-2
[0092] Experimental Example 1-2: Changes in Auditory Brainstem Response (ABR) Threshold
[0093] To assess auditory brainstem responses, all experimental animals were injected intramuscularly with a mixture of xylazine (5 mg / kg) and ketamine for anesthesia, and the auditory brainstem was measured using a TDT system (Tucker-Davis Technologies, FL, USA) in a soundproof room. Changes in dry response threshold.
[0094] An insertable ear tip (3.5 mm, Nicolet Biomedical) was placed in the external auditory canal and electrodes were placed in the apex of the scalp (active electrode), mastoid region of the ear of interest (control electrode) and on the opposite ear. mastoid region (ground electrode), and the threshold of ABR was determined by an initial 90 dB HL intensity followed by a sequential 10 dB decrease at 4, 8, 16 and 32 kHz.
[0095] During the ABR test, no arousal response and death due to respiratory depression occurred. ABR thresholds between groups were compared by on...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap